fate therapeutics stock price today

Fate Therapeutics Inc. The Stock rose vividly during the last session to 2130 after.

Sec Filing Fate Therapeutics Inc

7 Small-Cap Stocks to Buy Before the Bull Market Returns InvestorPlace Aug 7 2022 See All News About Fate Therapeutics Inc.

. View real-time stock prices and stock quotes for a full financial overview. Immunotherapy stocks power higher on Celgene-Juno deal Shares of immunotherapy companies including Ziopharm Oncology and Fate Therapeutics rose early on. Key Stock Data PE Ratio TTM NA EPS TTM -264 Market Cap 208 B Shares.

Its pipeline of products includes. View the latest FATE stock quote and chart on MSN Money. FATE Quote Market Cap Chart WallStreetZen Fate Therapeutics Inc Stock Overview Forecast Earnings Dividend Ownership.

Get the latest Fate Therapeutics Inc FATE detailed stock quotes stock data Real-Time ECN charts stats. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Msn back to msn.

News Fate Therapeutics Inc. FATE which is 1968 to be very precise. A high-level overview of Fate Therapeutics Inc.

Significant News Only No significant news for FATE in the past two years. 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO. Stock news by MarketWatch.

The analyst firm set a price target for 3500. View Fate Therapeutics Inc FATE investment stock information. The 23 analysts offering price forecasts for Fate Therapeutics have a median target of 8783 with a high estimate of 13000 and a low estimate of 2800.

FATE was reported by Morgan Stanley on Friday September 9 2022. Shares Out 9700M 10 Day Average Volume 110M Dividend - Dividend Yield - Beta 168 YTD Change -6397 RATIOSPROFITABILITY EPS TTM -264 PE TTM -799 Fwd PE. According to 28 analysts the average rating for FATE stock is Buy The 12-month stock price forecast is 7397 which is an increase of 24679 from the latest price.

FATE Complete Fate Therapeutics Inc. Lets start up with the current stock price of Fate Therapeutics Inc. Dive deeper with interactive charts and top stories of FATE THERAPEUTICS INC.

Fate Therapeutics Inc Fate Stock Price Quote News Stock Analysis Share this post. The stock was sold at an average price of. 2 days agoIn other Fate Therapeutics news CEO J Scott Wolchko sold 30000 shares of the stock in a transaction on Thursday July 21st.

The latest price target for Fate Therapeutics NASDAQ. Iklan Tengah Artikel 2. Engages in the development of programmed cellular immunotherapies for cancer and immune disorder.

The shares were sold at an average price of. NASDAQFATEs beta value is holding at 166 while the average true range ATR indicator is currently reading 156. Iklan Tengah Artikel 1.

Fate Therapeutics Stock Price Today NASDAQ. 263 DNA154 Schrodinger Inc 2240 SDGR224 Twist Bioscience Corp 3139 TWST960 In the news Yahoo Finance 1 day ago While Fate Therapeutics NASDAQFATE shareholders. In related news CFO Edward J.

Dulac III sold 5135 shares of Fate Therapeutics stock in a transaction on Thursday August 18th.

Is Fate Therapeutics Inc Fate Stock A Bad Value Wednesday